STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable grants.
ARPA-H, the U.S.’ “moonshot” agency for health research, announced Thursday that it will spend up to $160 million to push forward custom gene editing treatments for a spate of rare diseases. The program, called THRIVE, will back seven different teams pursuing various groups of conditions affecting different organ systems. Each team has a deadline of starting clinical trials by year three of the program, although some may start much sooner. Continue to STAT+ to read the full story…
Đọc thêm từ Sức khỏe
Why some people are more bothered by low-frequency sounds
Some people are more sensitive to low-frequency noise, such as from ventilation systems, heat pumps, wind turbines and transformers. Why is that?
Researchers hone new AI method to track 'smart' vapes with digital screens
E-cigarettes, also known as vapes, are battery-operated devices that heat a liquid that typically contains nicotine, an addictive substance. These devices are continually changing, with new flavors, novel device designs and digital screens. Some of these e-cigarettes—sometimes ca
STAT+: FDA finalists under review
Three top contenders to run the FDA are under review by the White House
AI can't replace mental health therapists. But here's where it might make a difference
A person wakes in the middle of the night, overwhelmed and needing someone to talk to. But instead of calling a loved one or booking a counseling session, they open ChatGPT.